Rhythm Pharmaceuticals (RYTM) Interest Expenses (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Interest Expenses of $4.6 million for Q1 2026, down 15.27% year-over-year from $5.4 million in Q1 2025, and down 0.69% quarter-over-quarter from $4.6 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Interest Expenses (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Interest Expenses for 11 consecutive years, with $4.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses fell 15.27% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $19.8 million (down 2.26% YoY), while the FY2025 annual figure was $381.2 million, up 17.1% from the prior year.
- Interest Expenses fell to $4.6 million in Q1 2026 per RYTM's latest filing, from $4.6 million in the prior quarter.
- Across five years, Interest Expenses topped out at $5.9 million in Q3 2024 and bottomed at $2.6 million in Q2 2022.
- Historically, Interest Expenses has averaged $4.2 million across 5 years, with a median of $4.6 million in 2026.
- On a YoY basis, Interest Expenses climbed as much as 229.26% in 2022 and fell as far as 23.76% in 2022.
- Rhythm Pharmaceuticals' Interest Expenses stood at $3.0 million in 2022, then soared by 51.11% to $4.6 million in 2023, then climbed by 19.71% to $5.4 million in 2024, then fell by 15.27% to $4.6 million in 2025, then declined by 0.69% to $4.6 million in 2026.
- Business Quant data shows RYTM's Interest Expenses at $4.6 million in Q1 2026, $4.6 million in Q4 2025, and $4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 4.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.54 Mn |
| Jun 30, 2026 | 4.54 Mn |
| Mar 31, 2026 | 4.58 Mn |
| Mar 31, 2026 | 4.58 Mn |
| Dec 31, 2025 | 4.62 Mn |
| Dec 31, 2025 | 4.62 Mn |
| Sep 30, 2025 | 4.74 Mn |
| Sep 30, 2025 | 4.74 Mn |
| Jun 30, 2025 | 5.82 Mn |
| Jun 30, 2025 | 5.82 Mn |
| Mar 31, 2025 | 5.41 Mn |
| Mar 31, 2025 | 5.41 Mn |
| Dec 31, 2024 | 5.45 Mn |
| Dec 31, 2024 | 5.45 Mn |
| Sep 30, 2024 | 5.91 Mn |
| Sep 30, 2024 | 5.91 Mn |
| Jun 30, 2024 | 4.60 Mn |
| Jun 30, 2024 | 4.60 Mn |
| Mar 31, 2024 | 4.76 Mn |
| Mar 31, 2024 | 4.76 Mn |